DCW targets ₹300 crore steady-state EBITDA, net debt-free by FY27
- DCW revenue rose 14% YoY to ₹542 crore in Q1 FY27
- Consolidated EBITDA fell 28% to ₹41.4 crore due to Basic Chemicals pressure
- Management targets ₹300 crore steady-state EBITDA and net debt-free status by FY27
- Approved ₹250 crore capex for SIOP expansion and power efficiency improvements

*this image is generated using AI for illustrative purposes only.
DCW Limited reported a 14% year-on-year revenue increase to ₹542 crore for the quarter ended June 30, 2026. While consolidated EBITDA fell 28% to ₹41.4 crore due to pressures in the Basic Chemicals segment, management outlined a clear path forward, targeting a ₹300 crore steady-state EBITDA and aiming to become effectively net debt-free by the end of FY27.
Financial Performance Overview
The divergence between revenue growth and margin contraction highlights the impact of external disruptions on the Basic Chemicals segment. While Specialty Chemicals EBITDA grew approximately 20% year-on-year, the Basic Chemicals segment reported a negative EBITDA of ₹14 crore. This loss was attributed to lower PVC production volumes, elevated Vinyl Chloride Monomer (VCM) prices due to West Asia conflicts, and the temporary suspension of import duties that pressured domestic realizations.
| Metric | Q1 FY27 | Change (YoY) |
|---|---|---|
| Revenue | ₹542 crore | +14% |
| EBITDA (incl. other income) | ₹41.4 crore | -28% |
| Finance Cost | ₹14.8 crore | -2% |
| Depreciation | ₹26 crore | Stable |
Sequentially, revenue declined 11% compared to Q4 FY26. Management attributed this drop to a one-time base effect from exceptional inventory liquidation of Synthetic Rutile in the previous quarter, alongside higher captive consumption of PVC for CPVC production and lower overall PVC output.
Strategic Outlook and Capex Plans
Management indicated that the pressures faced in Q1 were largely event-driven rather than structural. With VCM availability improving and normal import duties reinstated, the operating environment for PVC is expected to normalize. DCW announced a ₹250 crore investment program over the next two to three years, focusing on:
- Expanding Synthetic Iron Oxide Pigment capacity from 30,000 tons to 45,000 tons per annum, with Phase 1 (7,000 tons) targeted for completion in Q4 FY28.
- Investing in captive power infrastructure at the Sahupuram facility to structurally lower power costs.
The company aims to become effectively net debt-free by the end of FY27 after repaying legacy long-term debt. Finance costs decreased 2% year-on-year to ₹14.8 crore, reflecting ongoing deleverage efforts. Management targets a minimum incremental Return on Capital Employed (ROCE) of 20% on new investments and expects steady-state EBITDA to reach ₹300 crore.
What the Numbers Show
The financial results reveal a stark bifurcation in business resilience. The Specialty Chemicals segment demonstrated operational strength with volume-led growth, while the Basic Chemicals segment absorbed the brunt of geopolitical supply chain shocks. The fact that Specialty Chemicals accounted for 33% of revenue but drove positive EBITDA growth, while Basic Chemicals generated 67% of revenue but resulted in a segment loss, underscores DCW’s strategic pivot toward higher-margin value-added products. Furthermore, the company’s decision to migrate to the new concessional tax regime reduced net deferred tax liability by ₹34 crore, providing a non-operational buffer against the operating loss in the core chemical business.
Leadership Transition
In a significant organizational move, DCW appointed Sudarshan Ganapathy as Chief Executive Officer. President Saatvik Jain highlighted that this transition coincides with the company’s shift from strengthening its foundation to building for the next phase of growth, leveraging a diversified portfolio and integrated manufacturing platform.
Historical Stock Returns for DCW
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.91% | +0.71% | -0.62% | +4.72% | -37.16% | 0.0% |
How will the new CEO, Sudarshan Ganapathy, prioritize the ₹250 crore capex plan between Synthetic Iron Oxide expansion and captive power infrastructure to achieve the targeted 20% ROCE?
What specific hedging strategies or supply chain adjustments is DCW implementing to mitigate future EBITDA volatility in the Basic Chemicals segment given geopolitical risks in West Asia?
Given the sequential revenue decline and reliance on Specialty Chemicals for margin stability, what is the projected timeline for the Basic Chemicals segment to return to positive EBITDA?


































